Atlas FDA

ImmuLisa Enhanced RNA POL III Antibody ELISA

FDA 510(k) clearance K172078 · decided 2018-03-30

Clearance details

K-number
K172078
Device name
ImmuLisa Enhanced RNA POL III Antibody ELISA
Applicant
Immco Diagnostics, Inc.
Decision
Substantially Equivalent
Date received
2017-07-10
Decision date
2018-03-30
Days to decision
263 days
Clearance type
Traditional
Product code
NYO
Device class
2
Regulation number
866.5100
Medical specialty
Immunology
Advisory committee
Immunology
Location
Buffalo, NY, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Immco Diagnostics

The Builder collects up to 8 candidate devices side by side with yours, then exports the substantial-equivalence comparison scaffold. How it works

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
EliA RNA Pol III (K202541)Phadia AB2021-09-13
QUANTA LITE RNA POL III ELISA (K070066)Inova Diagnostics, Inc.2007-04-11
ANTI RNA POLYMERASE III ELISA KIT, MODEL 7805 (K060431)Mbl International Corporation2006-06-19

Recalls involving this device

No recalls on record reference this clearance.